These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 31744021

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease.
    Oelkers W, Bähr V.
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):325-30. PubMed ID: 3039766
    [Abstract] [Full Text] [Related]

  • 24. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL, Levitt NS, Van der Walt JS, Schatz DA, Johannsson G, Haarburger DH, Pillay TS.
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [Abstract] [Full Text] [Related]

  • 25. Corticosteroids and the cardiovascular response to stress: a pilot study of the 35% CO2 challenge in Addison's disease.
    Kaye JM, Lightman SL.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):282-6. PubMed ID: 16918945
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL, Lewis JG, Rees LH.
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):131-9. PubMed ID: 212238
    [Abstract] [Full Text] [Related]

  • 28. Hypothyroidism and Addison's disease totally corrected by adrenal replacement therapy.
    Schwartz WL.
    Calif Med; 1973 Feb; 118(2):57-60. PubMed ID: 4701710
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Successful pregnancy outcome in a patient with primary Addison's disease.
    Adonakis G, Georgopoulos NA, Michail G, Spinos N, Papadopoulos V, Kourounis GS, Kyriazopoulou V.
    Gynecol Endocrinol; 2005 Aug; 21(2):90-2. PubMed ID: 16109594
    [Abstract] [Full Text] [Related]

  • 33. [Addison disease during pregnancy--a diagnostic dilemma. Symptoms are similar to normal pregnancy problems].
    Wålinder O.
    Lakartidningen; 2005 Aug; 102(26-27):1988-90. PubMed ID: 16044755
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cutaneous hyperpigmentation and polyglandular autoimmune syndrome type II.
    Chung AD, English JC.
    Cutis; 1997 Feb; 59(2):77-80. PubMed ID: 9040976
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA, Livesey JH, Florkowski C, Or HK, Donald RA, Espiner EA.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [Abstract] [Full Text] [Related]

  • 40. [Addison's disease].
    Quinkler M.
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):454-9. PubMed ID: 22907517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.